PPARA and metabolic dysfunction-associated steatotic liver disease: In this study, the results showed that expressions of AdipoR2, PPAR-α, and CPT1 mRNAs in the liver of NAFLD rats were significantly downregulated, which were reversed by treatment with HXQYF (45 mg/kg) in NAFLD rats.